THE EFFECTIVENESS OF VASCULAR RECANALIZATION METHODS IN PATIENTS WITH ACUTE ISCHEMIC STROKE AT E HOSPITAL
Main Article Content
Abstract
Background: Acute ischemic stroke is a leading cause of disability and mortality worldwide. Early vascular recanalization is an effective treatment strategy that improves survival and functional outcomes. In Vietnam, real-world data on clinical characteristics and outcomes of reperfusion therapies at central hospitals remain limited. Objective: To describe the clinical and paraclinical characteristics and treatment outcomes of patients with acute ischemic stroke undergoing vascular reperfusion at E Hospital. Methods: A cross-sectional descriptive study was conducted on 81 patients treated for acute ischemic stroke at E Hospital between November 2020 and March 2023. Data were collected from medical records, brain CT imaging, clinical scoring, and follow-up at 3 months. Results: Hypertension was the most common risk factor (64.2%), followed by prior ischemic stroke (22.2%) and diabetes mellitus (14.8%). Early brain CT changes were observed in 40.7% of patients and were significantly associated with higher NIHSS scores (p = 0.048). Intravenous thrombolysis was used in 65.5% of cases, mechanical thrombectomy in 8.6%, and combination therapy in 25.9%. The rate of good functional recovery (mRS 0–2 at 3 months) did not differ significantly between treatment groups (p = 0.742). Favorable prognostic factors included age ≤ 60 years, NIHSS < 10 at admission, and onset-to-needle time ≤ 180 minutes. Conclusion: Reperfusion therapies yield comparable outcomes when performed timely. The study highlights the importance of early assessment, risk stratification, and individualized treatment strategies in improving functional outcomes among patients with acute ischemic stroke in Vietnam.
Article Details
Keywords
Acute ischemic stroke; Reperfusion therapy; rtPA; Mechanical thrombectomy; NIHSS; mRS; Brain CT scan.
References
2. Kim H, Kim JT, Kim BJ, et al. Tenecteplase in Acute Ischemic Stroke: A Scientific Statement From the Korean Stroke Society. Journal of Clinical Neurology. 2025;21. doi:10.3988/jcn. 2025.0210
3. Ma L, Cheng Z, Rajah GB, Yun HJ, Geng X, Ding Y. Efficacy and procedural efficiency of mechanical thrombectomy devices in posterior circulation stroke. Front Neurol. 2025;16. doi:10.3389/fneur.2025.1620092
4. Musmar B, Salim HA, Adeeb N, et al. Outcomes of mechanical thrombectomy for medium vessel occlusion in acute ischemic stroke patients with ASPECTS 4-5 vs. 6-7: a retrospective, multicenter, and multinational study. Neuroradiology. 2025;67(1):201-211. doi:10.1007/s00234-024-03500-1
5. Berkhemer OA, Fransen PSS, Beumer D, et al. A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke. New England Journal of Medicine. 2015;372(1):11-20. doi:10.1056/ NEJMoa1411587
6. Albers GW, Marks MP, Kemp S, et al. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. New England Journal of Medicine. 2018;378(8):708-718. doi:10.1056/NEJMoa1713973
7. Goyal M, Menon BK, van Zwam WH, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016;387(10029):1723-1731. doi:10.1016/S0140-6736(16)00163-X
8. Saver JL, Goyal M, Bonafe A, et al. SolitaireTM with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial: protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tPA with IV tPA alone in acute ischemic stroke. Int J Stroke. 2015;10(3):439-448. doi:10.1111/ijs.12459